Back

Spyre Therapeutics Stock Predictions

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Sell

SYRE
Spyre Therapeutics

Last Price:

27.50

Seasonality Move:

-1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Spyre Therapeutics Stock Forecast

Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 25.6% based on the past 8 years of stock performance.
Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Is Spyre Therapeutics Stock Undervalued?
The current Spyre Therapeutics [SYRE] share price is $27.50. The Score for SYRE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 25.6% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell

Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

spyre.com

52-Week Data

52-Week High:

47.97

52-Week Low:

8.75

Prediction Charts

Market Cap:

1.61B

Price in USD:

27.50

Volume:

1.24M

Beta:

2.53

Technical Analysis

SMA50:

31.20

SMA100:

29.36

SMA200:

31.23

52-Wk Change:

161.9%

Stock Predictions

Is Spyre Therapeutics stock public?
Yes, Spyre Therapeutics is a publicly traded company.
What is the Spyre Therapeutics stock quote today?
The Spyre Therapeutics stock price is 27.50 USD today.
How to buy Spyre Therapeutics stock online?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-1	32.72	33.98	34.13	32.72
Nov-4	33.59	35.09	35.46	33.10
Nov-5	35.30	35.92	36.08	34.68
Nov-6	37.00	37.48	38.05	35.91
Nov-7	37.59	37.69	38.73	36.92
Nov-8	35.87	39.58	39.63	33.00
Nov-11	38.85	39.35	40.09	38.61
Nov-12	39.57	35.75	40.26	35.42
Nov-13	36.39	32.98	36.98	32.23
Nov-14	33.03	31.27	33.47	31.16
Nov-15	31.35	29.20	31.35	29.14
Nov-18	29.27	28.67	30.34	28.41
Nov-19	27.73	26.90	27.80	25.74
Nov-20	26.86	27.50	28.48	26.81

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.